Actively Recruiting
INS, B Cells and Microbiota
Led by Nantes University Hospital · Updated on 2026-03-03
30
Participants Needed
2
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Idiopathic nephrotic syndrome (NIS) is a clinical entity defined by the association of selective albuminuria, hypoalbuminemia, and nonspecific glomerular lesions (lesions minimal glomerular (LGM) or segmental and focal hyalinosis (HSF). The complication of this kidney disease is the progression towards chronic renal failure and in case of kidney transplantation, its immediate recurrence on the graft . The origin of this syndrome is unknown but a number of clinical observations tend to show an involvement of immune system. A link has been highlighted between atopy, diet and nephrotic flare-ups. The speed of recurrence of this initial disease on the graft and the observation of remissions obtained after treatment by plasma exchange or immunoadsorptions support the presence of a pathogenic plasma factor. Anti-CD20 treatments depleting B lymphocytes has made it possible to favorably treat a number of patients. Dysfunction of regulatory T cells has also been shown in SNI patients. This modification seems linked to allergies and could be due to an aberrant microbiota. The hypothesis of causality between dysbiosis, alteration lymphocyte and triggering of an SNI was mentioned recently. Two studies have shown intestinal dysbiosis in pediatric SNI/LGM, with reduction of T circulating regulators
CONDITIONS
Official Title
INS, B Cells and Microbiota
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated in participating centers
- Currently experiencing a nephrotic syndrome attack defined by proteinuria > 3g/24h, or a proteinuria/creatinuria ratio > 3, or as determined by the clinician
You will not qualify if you...
- History of nephrotic syndrome flare-ups resistant to corticosteroid therapy
- Treatment with immunosuppressants
- Treatment with corticosteroids > 10 mg per day
- Weight less than 50 kg
- Pregnant woman
- Patient under guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093
Actively Recruiting
2
Departemental Hospital Center
La Roche-sur-Yon, France, 85925
Actively Recruiting
Research Team
C
Christophe Masset
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here